News
Capsule Photonics wins Venture Challenge Winter 2024/2025!
The winner of the Venture Challenge was announced today at Innovation for Health. The proud winner of the 2024/2025 Winter edition is Capsule Photonics! The team has developed an innovative capsule endoscope: a pill-sized camera that creates microscopy-like images, highlighting areas where cancer biomarkers are present.
UNIIQ invests €2.1 million in six innovative South Holland startups
UNIIQ, the proof-of-concept investment fund of the South Holland region, has announced six new investments in promising startups, totaling €2.1 million. These strategic investments contribute to the further development of both the participating companies and the broader innovation ecosystem in the region. The announcement was made by Meindert Stolk, Provincial Executive for Economy and Innovation of the Province of South Holland.
Four LS@W Venture Challenge alumni among finalists for Innovation for Health 2025 Start-up Pitch Contest
The Global Investor Forum jury has announced the nine finalists for the 2025 Innovation for Health Start-up Pitch Contest, powered by Axon Lawyers and F.INSTITUTE.
SLAM Orthopedic secures €1.1 million Innovation Credit to bring smart fracture surgery tool to market
SLAM Orthopedic, winner of the Venture Challenge Fall 2020, has secured €1.1 million in Innovation Credit from the Netherlands Enterprise Agency (RVO).
Cyclomics and Oncode Investigator Jeroen de Ridder receive Health~Holland PPP subsidy
Cyclomics and Oncode Investigator Jeroen de Ridder receive Health~Holland PPP subsidy to advance real-time brain tumor diagnostics.
New Initiative: Drug Repurposing Venture Challenge Launches
Today marks the exciting launch of a new collaboration between ZonMw and FAST: The Drug Repurposing Venture Challenge. This innovative program challenges researchers to transform scientific breakthroughs in drug repurposing into robust plans, ready for market entry and patient benefit—all within three months. Deadline for team registration: May 20, 2025.
TargED Biopharmaceuticals’ TGD001 receives Orphan Drug Designation in the United States of America
TargED Biopharmaceuticals B.V., a clinical-stage private biotechnology company focused on developing improved treatments for thrombotic diseases, today announces that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its lead product TGD001, a von Willebrand factor targeted thrombolytic, for the treatment of thrombotic thrombocytopenic purpura (TTP).
Sirius Medical and Mammotome Partner to Distribute Sirius Pintuition® Across the United States and Germany
Cincinnati, Ohio, US and Eindhoven, Netherlands – February 27, 2025 - Sirius Medical, the innovator of Surgical Marker Navigation and Mammotome, a globally recognized leader in breast care, are proud to announce an exclusive distribution agreement for the United States and Germany. This collaboration combines the extensive breast care knowledge and commercial capabilities of Mammotome with Sirius Medical’s technology and innovation.
The Netherlands meets Minnesota in Medtech
Are you a startup, scale-up or SME active in the medical technology sector? Do you develop medical end products or technologies? Do you have ambitions to enter the American market or grow further there?